Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIO Bio Rad实验室

交易中 05-07 14:33:57 EDT

281.22

-0.75

-0.27%

最高282.96	最低278.88	成交量8.69万
今开282.75	昨收281.97	日振幅1.45%
总市值80.20亿	流通市值56.12亿	总股本2,852万
成交额2,439万	换手率0.44%	流通股本1,996万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIO","market":"US","secType":"STK","nameCN":"Bio Rad实验室","latestPrice":281.22,"timestamp":1715106832795,"preClose":281.97,"halted":0,"volume":86911,"delay":0,"floatShares":19956993,"shares":28518436,"eps":-21.82,"marketStatus":"交易中","marketStatusCode":2,"change":-0.75,"latestTime":"05-07 14:33:57 EDT","open":282.745,"high":282.96,"low":278.88,"amount":24393242.57942,"amplitude":0.01447,"askPrice":281.51,"askSize":5,"bidPrice":281.01,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-21.82,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715112000000},"adr":0,"adjPreClose":281.97,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":282,"preClose":281.97,"latestTime":"08:27 EDT","volume":5,"amount":1410,"timestamp":1715084867981},"postHourTrading":{"tag":"盘后","latestPrice":281.97,"preClose":281.97,"latestTime":"16:20 EDT","volume":29650,"amount":8360409.3,"timestamp":1715026801111},"volumeRatio":0.418721},"requestUrl":"/m/hq/s/BIO/wiki","defaultTab":"wiki","newsList":[{"id":"2432048499","title":"KALA BIO Inc   预计每股亏损 2.89 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432048499","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432048499?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:07","pubTimestamp":1714748861,"startTime":"0","endTime":"0","summary":"   * KALA BIO Inc    预计在5月7日公布截至2024年3月31日的财报时，季度营收将保持不变(预计)    *    * LSEG的分析师平均预计KALA BIO公司每股亏损2.89美元。* 华尔街对 KALA BIO Inc 的 12 个月目标价中位数为 21.00 美元，高于其上次收盘价 6.75 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429692113","title":"Bio Rad实验室盘中异动 早盘急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429692113","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429692113?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:09","pubTimestamp":1713881358,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时09分，Bio Rad实验室股票出现波动，股价急速拉升5.07%。截至发稿，该股报294.33美元/股，成交量2.9899万股，换手率0.10%，振幅2.93%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.77%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司为临床诊断和生命科学市场制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232209187a54efc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232209187a54efc7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428591529","title":"Bio Rad实验室盘中异动 急速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591529","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428591529?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:33","pubTimestamp":1713447198,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时33分，Bio Rad实验室股票出现异动，股价急速下挫5.04%。截至发稿，该股报276.20美元/股，成交量2451股，换手率0.01%，振幅0.00%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为0.21%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司为临床诊断和生命科学市场制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213318861e7113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213318861e7113&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427002613","title":"Bio Rad实验室跌0.57% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2427002613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427002613?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:48","pubTimestamp":1713192529,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时48分，Bio Rad实验室股票出现异动，股价急速下挫0.57%。截至发稿，该股报298.75美元/股，成交量1.8359万股，换手率0.06%，振幅1.45%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.42%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司为临床诊断和生命科学市场制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415224850861e5d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415224850861e5d72&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426929184","title":"Bio Rad实验室盘中异动 股价大跌5.09%报314.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426929184","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426929184?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:48","pubTimestamp":1712861329,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日02时48分，Bio Rad实验室股票出现波动，股价急速跳水5.09%。截至发稿，该股报314.25美元/股，成交量18.3594万股，换手率0.64%，振幅4.75%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.16%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司为临床诊断和生命科学市场制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120248507a5231f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120248507a5231f4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423619934","title":"KALA BIO 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2423619934","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423619934?lang=zh_cn&edition=full","pubTime":"2024-03-29 21:09","pubTimestamp":1711717765,"startTime":"0","endTime":"0","summary":"   * KALA BIO Inc   报告，截至12月底的季度调整后每股亏损3.18美元，高于去年同期的每股收益7.97美元。三位分析师对该季度的平均预期是每股亏损 3.62 美元。华尔街预期为每股亏损 4.00 美元至 3.08 美元。* KALA BIO Inc 公布的季度每股收益为亏损 3.18 美元。* KALA BIO Inc 本季度股价上涨了 12.1%。华尔街对 KALA BIO Inc 的 12 个月目标价中位数为 22.00 美元。本摘要由 LSEG 3 月 29 日 01:09 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420262402","title":"药明康德回应主动退出BIO 系为让BIO继续专注从行业角度跟政策制定者有效沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2420262402","media":"北京商报","top":-1,"share":"https://www.laohu8.com/m/news/2420262402?lang=zh_cn&edition=full","pubTime":"2024-03-19 11:52","pubTimestamp":1710820335,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）3月19日，据媒体报道称，药明康德（603259）在2023年业绩电话会上，针对此前主动申请终止BIO会员资格一事作出回应，药明康德表示，公司3月12日主动致信退出BIO，是为了能让BIO更专注地从行业角度跟政策制定者进行有效沟通，提升对行业的理解，同时提高公众对医药产业的意识。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403193016489040.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403193016489040.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419999273","title":"港股异动 | 药明康德(02359)续跌超5% 美知名生物技术组织BIO修改并更新 是药明康德主动终止会员资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2419999273","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2419999273?lang=zh_cn&edition=full","pubTime":"2024-03-15 11:15","pubTimestamp":1710472549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德(02359)续跌超5%，2个交易日大跌16%，截至发稿，跌5.01%，报42.70港元，成交额4.34亿港元。消息面上，据财联社报道，今日在美国知名生物技术组织BIO(Biotechnology Innovation organization)官网获悉，BIO在美国时间3月14日修改并更新了其于13日发布的一则新闻稿内容：修改前的“BIO目前正在采取措施，在组织成员资格方面与药明康德(WuXi-AppTec)分开”的内容，已被更新为“药明康德主动终止其BIO会员资格”。尚未从药明康德方面获得相关回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1086851.html","is_publish_highlight":false,"gpt_icon":0},{"id":"1105095127","title":"美知名生物技术组织BIO修改并更新：是药明康德主动终止会员资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1105095127","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1105095127?lang=zh_cn&edition=full","pubTime":"2024-03-15 10:14","pubTimestamp":1710468844,"startTime":"0","endTime":"0","summary":"3月15日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO在美国时间3月14日修改并更新了其于13日发布的一则新闻稿内容：修改前的“BIO目前正在采取措施，在组织成员资格方面与$药明康德(603259)$（WuXi-AppTec）分开”的内容，已被更新为“$药明康德(02359)$主动终止其BIO会员资格”。","market":"hk","thumbnail":"https://static.tigerbbs.com/25615b9ed04b783f53779f6d182e17b2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25615b9ed04b783f53779f6d182e17b2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"gpt_icon":0},{"id":"2419896838","title":"早报 (03.15）| SpaceX“星舰”第三次试飞失联；今日下午，李超将发声！央行重磅发声；国家发改委发布重大利好；华为新成绩单公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2419896838","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2419896838?lang=zh_cn&edition=full","pubTime":"2024-03-15 07:44","pubTimestamp":1710459879,"startTime":"0","endTime":"0","summary":"杭州重磅！全面取消；蚂蚁、京东“王炸”","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/120.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/120.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/707357","is_publish_highlight":false,"gpt_icon":0},{"id":"2419623246","title":"药明系股价午后跌幅扩至12%-17%  交投活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2419623246","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419623246?lang=zh_cn&edition=full","pubTime":"2024-03-14 15:32","pubTimestamp":1710401520,"startTime":"0","endTime":"0","summary":"美国生物技术创新组织(BIO)转(车太)支持《生物安全法案》，并采取措施剔除药明康德(02359.HK) 的会员资格。药明系股价午后跌幅进一步扩大，尤其是药明合联(02268.HK) 低见16.3元，现报16.38元，急挫17%，成交增至1,0551万股。蓝筹药明康德及药明生物(02269.HK) 均失守10天及20天线，午后低见44元及15.82元，现报44.9元及15.98元，急挫12%及14%，成交分别增至2,299万股及1.41亿股。(sz/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-14 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190703175731745_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190703175731745_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333429/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2419526649","title":"药明康德AH股齐下挫 美国BIO称将剔除药明康德会员资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2419526649","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2419526649?lang=zh_cn&edition=full","pubTime":"2024-03-14 14:02","pubTimestamp":1710396147,"startTime":"0","endTime":"0","summary":"3月14日，药明康德大跌，截至发稿，药明康德跌超8%，报52.14元，成交额超87亿元。港股药明康德跌超12%。消息面上，当地时间3月13日，美国生物技术创新组织（BIO）宣布，将与中国会员药明康德进行“分离”，剔除其会员资格。值得注意的是，近日，药明康德抛出第二轮10亿元股份回购计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403143012102714.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403143012102714.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419611441","title":"美国BIO称将剔除药明康德会员资格 创新药板块迎来冲击？","url":"https://stock-news.laohu8.com/highlight/detail?id=2419611441","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/2419611441?lang=zh_cn&edition=full","pubTime":"2024-03-14 11:08","pubTimestamp":1710385680,"startTime":"0","endTime":"0","summary":"　　创新药的崛起之路似乎并不平坦！　　昨晚传出的一份《关于全链条支持创新药发展实施方案的征求意见稿》刺激了市场的神经。今天早盘，港股创新药ETF一度飙涨近10%。原因还是药明康德，这只股票亦是高开低走，大跌近5%。3月13日晚间，就在国内在为创新药利好欢呼之时，据美国知名生物技术组织BIO官网公布，宣布将剔除WuXi会员资格，并将终止与其合作。对于整个创新药板块是否也有冲击？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/jsy/2024-03-14/doc-inanhefw7961183.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/jsy/2024-03-14/doc-inanhefw7961183.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419328616","title":"港股异动 | CRO概念股转跌 药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2419328616","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2419328616?lang=zh_cn&edition=full","pubTime":"2024-03-14 10:53","pubTimestamp":1710384791,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与美国公司合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1086274.html","is_publish_highlight":false,"gpt_icon":0},{"id":"1139973071","title":"美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》","url":"https://stock-news.laohu8.com/highlight/detail?id=1139973071","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1139973071?lang=zh_cn&edition=full","pubTime":"2024-03-14 10:43","pubTimestamp":1710384203,"startTime":"0","endTime":"0","summary":"3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与药明康德（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。小财注：药明康德曾是BIO长期会员，今日在医药股大涨情况下，药明系港股跌幅均在9%左右。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2412977709","title":"Bio Rad实验室2023财年实现净利润-6.37亿美元，同比增加82.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412977709","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412977709?lang=zh_cn&edition=full","pubTime":"2024-02-19 00:24","pubTimestamp":1708273487,"startTime":"0","endTime":"0","summary":"12月31日，Bio Rad实验室公布财报，公告显示公司2023财年净利润为-6.37亿美元，同比增加82.44%；其中营业收入为26.71亿美元，同比减少4.68%，每股基本收益为-21.82美元。从资产负债表来看，Bio Rad实验室总负债35.58亿美元，其中短期债务41.37百万美元，资产负债比为3.46，流动比率为5.83。机构评级：截至2023年12月31日，当前有6家机构对Bio Rad实验室目标价做出预测，其中目标均价为420.93美元，其中最低目标价为350.00美元，最高目标价为480.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219002450819952ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219002450819952ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412966732","title":"Bio Rad实验室盘中异动 股价大涨7.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412966732","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412966732?lang=zh_cn&edition=full","pubTime":"2024-02-17 00:12","pubTimestamp":1708099921,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日00时12分，Bio Rad实验室股票出现异动，股价快速拉升7.45%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为1.03%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于加利福尼亚州赫拉克勒斯，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。在诊断领域，Bio-Rad 为临床实验室制造、销售测试系统和专业质量控制并为其提供支持。Bio-Rad 拥有实验室和生物制药供应商 Sartorius AG 37% 的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170012018192f7b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170012018192f7b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411302665","title":"Bio Rad实验室盘中异动 快速拉升6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411302665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411302665?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:32","pubTimestamp":1708093966,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日22时32分，Bio Rad实验室股票出现波动，股价快速拉升6.33%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.28%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于加利福尼亚州赫拉克勒斯，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。在诊断领域，Bio-Rad 为临床实验室制造、销售测试系统和专业质量控制并为其提供支持。Bio-Rad 拥有实验室和生物制药供应商 Sartorius AG 37% 的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622324687975213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622324687975213&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bio-rad.com","stockEarnings":[{"period":"1week","weight":0.0175},{"period":"1month","weight":-0.1313},{"period":"3month","weight":-0.1324},{"period":"6month","weight":-0.0759},{"period":"1year","weight":-0.2681},{"period":"ytd","weight":-0.1267}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-Rad Laboratories, Inc.成立于1952年并于1957年成立为公司。它早期致力于研究和生产用于生物化学，制药和其他生命科学研究运用的专用化学品。在其首次技术分离套件和生命科学研究材料都有所发展的情况下，它进入了临床诊断学领域。通过内部的研发努力和决策，它向不同的市场进行了扩张。现在，Bio-Rad为生命科学研究，医疗保健，分析化学和其他市场生产提供了一系列的产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.026111},{"month":2,"riseRate":0.590909,"avgChangeRate":0.01002},{"month":3,"riseRate":0.636364,"avgChangeRate":0.041103},{"month":4,"riseRate":0.622222,"avgChangeRate":0.043048},{"month":5,"riseRate":0.6,"avgChangeRate":0.017145},{"month":6,"riseRate":0.522727,"avgChangeRate":0.003978},{"month":7,"riseRate":0.568182,"avgChangeRate":0.003113},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.000841},{"month":9,"riseRate":0.431818,"avgChangeRate":-0.012093},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.006816},{"month":11,"riseRate":0.636364,"avgChangeRate":0.028116},{"month":12,"riseRate":0.659091,"avgChangeRate":0.024433}],"exchange":"NYSE","name":"Bio Rad实验室","nameEN":"Bio-Rad Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio Rad实验室,BIO,Bio Rad实验室股票,Bio Rad实验室股票老虎,Bio Rad实验室股票老虎国际,Bio Rad实验室行情,Bio Rad实验室股票行情,Bio Rad实验室股价,Bio Rad实验室股市,Bio Rad实验室股票价格,Bio Rad实验室股票交易,Bio Rad实验室股票购买,Bio Rad实验室股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况